1-4 of 4
Shelley Allen
Close
Sort by
Journal Articles

PIM: An Integral Component of FLT3 Signaling and a Potential Therapeutic Target in Acute Myeloid Leukemia.

Amir T. Fathi, Ian Swinnen, Trivikram Rajkhowa, Donald Small, Fredrik Marmsater, John E Robinson, Stefan David Gross, Matthew Martinson, Shelley Allen, Nick Kallan, Mark Levis
Journal: Blood
Blood (2009) 114 (22): 1735.
https://doi.org/10.1182/blood.V114.22.1735.1735
Published: 2009
Journal Articles

Characterization of the Effects of Pim Kinase Inhibition on Multiple Oncogene-Driven Cell Lines

Stefan David Gross, PhD, John E Robinson, Shelley Allen, April Cox, Walt E DeWolf, Sarah Galbraith, Patrice Lee, Christine Lemieux, Joseph P Lyssikatos, Fredrik Marmsater, Matthew Martinson, Mark C Munson, Ross D Wallace, Rich Woessner, John Zuzack, James Winkler, PhD, Kevin Koch
Journal: Blood
Blood (2008) 112 (11): 2662.
https://doi.org/10.1182/blood.V112.11.2662.2662
Published: 2008
Journal Articles

ARRY-429520, a Novel KSP Inhibitor with Potent Anti-Proliferative Activity in Leukemic Cell Lines.

Christine Lemieux, Walt DeWolf, Walt Voegtli, Eli Wallace, Rich Woessner, Chris Corrette, Shelley Allen, Jeremy Hans, Qian Zhao, Tom Aicher, Joe Lyssikatos, John Robinson, Kevin Koch, James Winkler, Stefan Gross
Journal: Blood
Blood (2006) 108 (11): 4401.
https://doi.org/10.1182/blood.V108.11.4401.4401
Published: 2006
Journal Articles

ARRY-429520, a KSP Inhibitor with Efficacy in Animal Models of Solid and Liquid Tumors.

Rich Woessner, PhD, Chris Corrette, Ph.D., Shelley Allen, Ph.D., Jeremy Hans, Ph.D., Qian Zhao, Ph.D., Tom Aicher, Ph.D., Joe Lyssikatos, Ph.D., John Robinson, Ph.D., Greg Poch, Ph.D., Laura Hayter, A.S., April Cox, M.S., Patrice Lee, Ph.D., James Winkler, Ph.D., Kevin Koch, Ph.D., Eli Wallace, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 4388.
https://doi.org/10.1182/blood.V108.11.4388.4388
Published: 2006